Close Menu

At the Medical Writing, Editing & Grantsmanship blog, this post notes the rising estimates of Challenge Grant applications. "Although the dust has not settled as yet, the NIH has currently accepted more than 18K RC1 applications, with another 11K in the error correction queue," according to the blogger. "CSR expects to engage 10K - 15K reviewers" -- which explains why you've probably gotten more than a few invitations already.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.

NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.

In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.